INFIMAS

The study of Initial limiting steps for fimbrae assembly in E.coli

Coordinatore	EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZURICH    more  Organization address address: Raemistrasse 101 city: ZUERICH postcode: 8092 contact info Titolo: Prof. Nome: Rudolf Cognome: Glockshuber Email: send email Telefono: 41446336819 Fax: +41 44 633 10 36
Nazionalità Coordinatore	Switzerland [CH]
Totale costo	256˙364 €
EC contributo	256˙364 €
Programma	FP7-PEOPLE Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
Code Call	FP7-PEOPLE-2011-IEF
Funding Scheme	MC-IEF
Anno di inizio	2013
Periodo (anno-mese-giorno)	2013-01-01   -   2014-12-31

 Partecipanti

#	participant	country	role	EC contrib. [€]
1	EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZURICH  Organization address address: Raemistrasse 101 city: ZUERICH postcode: 8092 contact info Titolo: Prof. Nome: Rudolf Cognome: Glockshuber Email: send email Telefono: 41446336819 Fax: +41 44 633 10 36	CH (ZUERICH)	coordinator	256˙364.20

Mappa

 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

 Obiettivo del progetto (Objective)

'Currently, the control of infectious diseases caused by pathogenic organelles displayed on bacteria is challenging for alternatives to antibiotic treatments. In this regard, the OMS report of 2010 alerted of the raising of antibiotic resistance for the control of human infections. Many of these pathogenic organelles, also known as pili or fimbriae, are assembled by a specific secretory machinery called the chaperone-usher pathway (CU). The aim of this proposal is the study of the initial steps required for the fimbriae assembly by the CU pathway (objectibe 1 and objective 3) and the identification of sequences involved in these steps (objective 2), using the E.coli Type 1 fimbriae prototype as the research model. The ultimate goal of INFIMAS project is the design of inhibitory peptides repertoires based on results obtained by the achievement of previous objectives, that will potentially overcome the bacterial resistance to the current antibiotics used for the treatment infectious diseases in EU and other countries. In addition, the results derived from INFIMAS project will have an additional impact on the general scientific knowledge of the European scientific community, in particular, on the study of pathogenic bacteria organelles. With regard to the fellow, the Marie Curie Fellowship will offer her the opportunity to achieve high impact publications, to be trained in complementary skills and obtain the international research experience required to reach a maturity position after the completion of the proposal, as INFIMAS project will be developed in a high reputed institution, such as The Swiss Federal Institute of Technology, and be supervised and advice by Prof Glockshuber, a well known expert in the field of pathogenic organelles using Type 1 fimbriae of E.coli as the research model.'